-
<![CDATA[FDA Approves Pirtobrutinib for Relapsed or Refractory CLL/SLL]]>
03 Dec 2025 22:30 GMT
… (Rituxan; IR) or bendamustine (Avastin) plus rituximab (BR; HR … open-label, active-controlled trial enrolled 238 patients with … (EFS), time to next treatment (TTNT), and safety.
… ;www.fda.gov/drugs/;resources-information-approved-drugs/fda-grants- …
-
<![CDATA[FDA Fast-Tracks Zotiraciclib for Recurrent High-Grade mIDH Glioma]]>
03 Dec 2025 04:46 GMT
… phase 1/2 trial (NCT05588141) evaluating zotiraciclib’ … bevacizumab (Avastin). Enrollment is open for the trial’s remaining … 1b STEAM trial (NCT03224104).8
REFERENCES
1. FDA grants … FDA grants orphan drug designation to zotiraciclib for the treatment of …
-
Anticancer Drugs Market Set to Expand at 9.14% CAGR, Reaching USD 401.32 Billion by 2034
21 Nov 2025 13:00 GMT
… drugs, making treatment more accessible. Focus on personalised medicine: … and emerging economies. Pharmaceutical companies are also … in Phase 3 trial
FDA resubmission
NCT05257408
Avmapki … HER2-positive breast cancer.
Avastin – Inhibits angiogenesis in various …
-
To Your Good Health: Debunking ivermectin as a ‘miracle treatment’ for cancer
21 Nov 2025 09:31 GMT
… . I am now on maintenance medications, Avastin and Lynparza. My numbers are … promising treatments turn out to be failures after the initial clinical trials … successful cancer treatments from being used.
Having known many doctors and research …
-
CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
17 Nov 2025 14:11 GMT
… trial treating glioblastoma patients with TPI 287 in combination with bevacizumab (Avastin … studies.
CNS Pharmaceuticals plans to engage the FDA and obtain feedback … pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment …
-
<![CDATA[Cancer Experts Share Emerging Treatments Patients Should Know in 2026 ]]>
13 Nov 2025 03:28 GMT
… continued innovation is transforming treatment across all cancer types … the future of precision medicine, novel therapeutic combinations, … nab-paclitaxel), relacorilant plus Avastin (bevacizumab), not only … available for clinical trials moving forward.
In …
-
<![CDATA[Tinostamustine Snags FDA Orphan Drug Designation for Malignant Glioma]]>
13 Nov 2025 03:21 GMT
… areas of serious, unmet medical need. We look forward … promise in early trials.”
FDA Orphan Drug Designation for Tinostamustine … #47;3 GBM AGILE trial (NCT03970447), which is … treatment with lomustine, agents in any experimental arm, and bevacizumab (Avastin …
-
Private cancer patients to get access to Pharmac-funded medicine
12 Nov 2025 05:37 GMT
… fund ongoing access to:
Bevacizumab (Avastin) for people with eye conditions … to administer than current intravenous treatments.
They were expected to save … drugs.
The Association of Salaried Medical Specialists, which represents 6500 senior hospital doctors …
-
STAT+: Pharmalittle: We’re reading about FDA naming Pazdur as top drug regulator, a cancer drug gold rush, and more
12 Nov 2025 15:19 GMT
… pharmaceutical giants are pouring billions into developing treatments linking old drugs … world’s best-selling medicines. The drugs are not based … and Roche’s Avastin into a single drug. With the … more money on clinical trials for thousands of patients. …
-
First cancer medicine available in private hospitals
12 Nov 2025 03:33 GMT
… -small cell lung cancer
Bevacizumab (Avastin) for people with eye conditions … medicine available in private clinics. When Pharmac fund a new cancer treatment … management through our faster cancer treatment target, strengthening early detection through …